Taimei Medical Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations (CROs), has raised RMB300 million ($48 million) in Series D funding.
Existing backers Matrix Partners China and Cowin Capital both re-upped for the new round. They are joined by a string of new investors, including SAIF Partners China, Morningside Ventures, Zhejiang Zheshang...
Yunwang Wandian, the e-commerce services arm of Suning.com, one of China’s largest retailers, has raised a RMB6 billion ($912 million) Series A round led by Shenzhen Capital Group.
Southeast Asia-focused private equity firm KV Asia Capital has exited TF Value Mart (TFVM), a Malaysia-based grocery retailer in which it has held a controlling stake since 2016, to Intermediate Capital Group (ICG).
NextGen Funds Management, a newly established GP in Australia, has launched what it is calling the country’s first dedicated artificial intelligence (AI) fund.
Hong Kong’s 3W Fund Management has led a $43 million Series E round for CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses cancer and rare diseases.